Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
TATAM RCT Demonstrates Superior Angiographic Outcomes with Transvenous Embolization in Stroke Management – Stroke AHA/ASA
depositphotos.com
Jun 13, 2025, 07:00

TATAM RCT Demonstrates Superior Angiographic Outcomes with Transvenous Embolization in Stroke Management – Stroke AHA/ASA

Stroke AHA/ASA posted on X:
“RCT results show that transvenous embolization is more effective than transarterial embolization in terms of angiographic results at 3-6 months, with comparable morbidity.”

Title: Transvenous Approach for the Treatment of Cerebral Arteriovenous Malformations: A Randomized Comparison With Transarterial Embolization.

Autors: Jean Raymond, Tim E. Darsaut, Suzana Saleme, Aymeric Rouchaud, Daniela Iancu, Daniel Roy, Alain Weill, Leonardo Olijnyk,  Roland Jabre, Michel W. Bojanowski, Chiraz Chaalala,  David Roberge, Kamel Boubagra, Olivier Heck, Jeremy L. Rempel, Chrysanthi Papagiannaki, Xavier Barreau, Gaultier Marnat, Jean-Christophe Gentric, Julien Ognard, Lorena Nico, Marc Bintner, Pascale Gauthier Lasalarie, Jean-Brice Veyrieres, Michel Piotin, Simon Escalard, Vitor M. Pereira, Daniel G. Abud, Justine Zehr, Miguel Chagnon, Thanh N. Nguyen, David Mathieu, Guylaine Gevry, BSc, Ruby Klink, Emmanuelle Lorian, Charbel Mounayer, TATAM Collaborative Group.

TATAM RCT Demonstrates Superior Angiographic Outcomes with Transvenous Embolization in Stroke Management - Stroke AHA/ASA

Full article via AHA Journals

 

Brief Analysis: TATAM RCT Findings
The TATAM randomized controlled trial compared transvenous embolization (TVE) versus transarterial embolization (TAE) in patients requiring endovascular intervention for cerebrovascular malformations.

Key Finding:
TVE demonstrated superior angiographic occlusion rates at 3–6 months follow-up, indicating more effective lesion closure.

Clinical Impact:
Despite a more technically complex route, TVE maintained morbidity rates comparable to TAE, supporting its safety profile.

Implication:
TVE may become the preferred embolization strategy for select cerebrovascular lesions, offering enhanced efficacy without increased risk.

See more in Hemostasis Today.

Alain Weill American Society of Hematology Angiographic Outcomes Aymeric Rouchaud Boston Medical Center BSc Cerebral Arteriovenous Malformations Charbel Mounayer Chiraz Chaalala Chrysanthi Papagiannaki Daniel G. Abud Daniel Roy Daniela Iancu David Mathieu David Roberge Emmanuelle Lorian Gaultier Marnat Guylaine Gevry Hemostasis Today Jean Raymond Jean-Brice Veyrieres Jean-Christophe Gentric Jeremy L. Rempel Julien Ognard Justine Zehr Kamel Boubagra Leonardo Olijnyk Lorena Nico Marc Bintner Michel Piotin Michel W. Bojanowski Miguel Chagnon Neurosurgery Platelet Count Olivier Heck Pascale Gauthier Lasalarie Roland Jabre Ruby Klink Simon Escalard Stroke AHA/ASA Stroke Management Suzana Saleme TATAM Collaborative Group. Thanh N. Nguyen Tim E. Darsaut Transvenous Embolization Vitor M. Pereira Xavier Barreau
NewsFeed